{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:29:13Z","timestamp":1793813353945,"version":"4.6.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:00:00Z","timestamp":1786752000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ibroneuroreports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IBRO Neuroscience Reports"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ibneur.2026.08.014","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:54:04Z","timestamp":1787068444000},"page":"747-753","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["PET-MRI effects of N-acetylcysteine in patients with multiple sclerosis"],"prefix":"10.1016","volume":"21","author":[{"given":"Daniel A.","family":"Monti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar Darabi","family":"Monadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0764-0612","authenticated-orcid":false,"given":"Feroze B.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Alizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Zabrecky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Wintering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8151-6291","authenticated-orcid":false,"given":"Monisha","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Steinmetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kremens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Bazzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8230-1752","authenticated-orcid":false,"given":"Andrew B.","family":"Newberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ibneur.2026.08.014_bib1","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/jon199884228","article-title":"High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis","volume":"8","author":"Bakshi","year":"1998","journal-title":"J. Neuroimag"},{"issue":"10","key":"10.1016\/j.ibneur.2026.08.014_bib2","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S1474-4422(20)30277-5","article-title":"Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues","volume":"19","author":"Benedict","year":"2020","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.ibneur.2026.08.014_bib3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1212\/WNL.53.1.149","article-title":"A longitudinal study of cerebral glucose metabolism, MRI, and disability in patients with MS","volume":"53","author":"Blinkenberg","year":"1999","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ibneur.2026.08.014_bib4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1177\/1352458510394609","article-title":"Distributed changes in default-mode resting-state connectivity in multiple sclerosis","volume":"17","author":"Bonavita","year":"2011","journal-title":"Mult. Scler."},{"key":"10.1016\/j.ibneur.2026.08.014_bib5","first-page":"1139","article-title":"Cognitive impairment in multiple sclerosis","volume":"7","author":"Chiaravalloti","year":"2008","journal-title":"Lancet Neurol. 2008"},{"key":"10.1016\/j.ibneur.2026.08.014_bib6","article-title":"Repeated-dose oral N-Acetylcysteine in Multiple sclerosis: Pharmacokinetics and effect on brain glutathione and oxidative stress","author":"Coles","year":"2017","journal-title":"J. Clin. Pharmacol."},{"issue":"1-2","key":"10.1016\/j.ibneur.2026.08.014_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jns.2005.09.017","article-title":"Reduced thalamic and cerebellar rest metabolism in relapsing-remitting multiple sclerosis, a positron emission tomography study: correlations to lesion load","volume":"245","author":"Derache","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ibneur.2026.08.014_bib8","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1136\/jnnp-2015-311375","article-title":"Recovery from an acute relapse is associated with changes in motor resting-state connectivity in multiple sclerosis","volume":"87","author":"Dogonowski","year":"2016","journal-title":"Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.ibneur.2026.08.014_bib9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1515\/BC.2003.059","article-title":"Glutathione pathways in the brain","volume":"384","author":"Dringen","year":"2003","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ibneur.2026.08.014_bib10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neubiorev.2014.07.016","article-title":"Associations of regional GABA and glutamate with intrinsic and extrinsic neural activity in humans\u2014a review of multimodal imaging studies","volume":"47","author":"Duncan","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ibneur.2026.08.014_bib11","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1177\/1352458516628657","article-title":"Depletion of brain functional connectivity enhancement leads to disability progression in multiple sclerosis: A longitudinal resting-state fMRI study","volume":"22","author":"Faivre","year":"2016","journal-title":"Mult. Scler."},{"issue":"11","key":"10.1016\/j.ibneur.2026.08.014_bib12","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/hipo.23001","article-title":"Altered hippocampal GABA and glutamate levels and uncoupling from functional connectivity in multiple sclerosis","volume":"28","author":"Gao","year":"2018","journal-title":"Hippocampus"},{"issue":"3","key":"10.1016\/j.ibneur.2026.08.014_bib13","first-page":"175","article-title":"Multiple sclerosis review","volume":"37","author":"Goldenberg","year":"2012","journal-title":"Pharm. Ther."},{"issue":"11","key":"10.1016\/j.ibneur.2026.08.014_bib14","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.3390\/jcm13113321","article-title":"Impact of cognitive impairment on quality of life in multiple sclerosis patients: A comprehensive review","volume":"13","author":"G\u00f3mez-Melero","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ibneur.2026.08.014_bib15","series-title":"User's Manual for the Medical Outcomes Study (MOS) Core Measures of Health-Related Quality of Life","author":"Hays","year":"1995"},{"issue":"4","key":"10.1016\/j.ibneur.2026.08.014_bib16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/WNF.0b013e31829ae713","article-title":"N-Acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases","volume":"36","author":"Holmay","year":"2013","journal-title":"Clin. Neuropharmacol."},{"issue":"2","key":"10.1016\/j.ibneur.2026.08.014_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.7224\/1537-2073-13.2.57","article-title":"Cognition and physical disability in predicting health-related quality of life in multiple sclerosis","volume":"13","author":"Hoogs","year":"2011","journal-title":"Inter. J. MS Care"},{"key":"10.1016\/j.ibneur.2026.08.014_bib18","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2217\/bmm-2016-0097","article-title":"Oxidative stress-related biomarkers in multiple sclerosis: a review","volume":"10","author":"Ibitoye","year":"2016","journal-title":"Biomark. Med."},{"issue":"3","key":"10.1016\/j.ibneur.2026.08.014_bib19","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/npr2.12360","article-title":"Effects of N-acetylcysteine on oxidative stress biomarkers, depression, and anxiety symptoms in patients with multiple sclerosis","volume":"43","author":"Khalatbari Mohseni","year":"2023","journal-title":"Neuropsychopharmacol. Rep."},{"key":"10.1016\/j.ibneur.2026.08.014_bib20","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nrneurol.2012.205","article-title":"Neuronal network connectivity is altered in multiple sclerosis","volume":"8","author":"Kingwell","year":"2012","journal-title":"Nat. Rev. Neurol."},{"issue":"11","key":"10.1016\/j.ibneur.2026.08.014_bib21","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S1474-4422(20)30346-X","article-title":"PET imaging of neuroinflammation in neurological disorders","volume":"19","author":"Kreisl","year":"2020","journal-title":"Lancet Neurol."},{"issue":"15_ement","key":"10.1016\/j.ibneur.2026.08.014_bib22","article-title":"N-acetyl cysteine for fatigue in progressive multiple sclerosis: A pilot randomized double-blind placebo-controlled trial (P5.2-093)","volume":"92","author":"Krysko","year":"2019","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ibneur.2026.08.014_bib23","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.neuroimage.2012.01.040","article-title":"Neuronal inhibition and excitation, and the dichotomic control of brain hemodynamic and oxygen responses","volume":"62","author":"Lauritzen","year":"2012","journal-title":"NeuroImage"},{"issue":"1424","key":"10.1016\/j.ibneur.2026.08.014_bib24","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1098\/rstb.2002.1114","article-title":"The neural basis of the blood-oxygen-level-dependent functional magnetic resonance imaging signal","volume":"357","author":"Logothetis","year":"2002","journal-title":"Philos. Trans. R. Soc. Lond. B. Biol. Sci."},{"key":"10.1016\/j.ibneur.2026.08.014_bib25","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s11910-012-0294-3","article-title":"Cognitive impairment in multiple sclerosis","volume":"12","author":"Lovera","year":"2012","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.ibneur.2026.08.014_bib26","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0006-8993(97)00493-9","article-title":"N-acetylcysteine protects against age-related increase in oxidized proteins in mouse synaptic mitochondria","volume":"762","author":"Mart\u00ednez-Banaclocha","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.ibneur.2026.08.014_bib27","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0024-3205(98)00472-X","article-title":"Hypothesis: can N-acetylcysteine be beneficial in Parkinson\u2019s disease?","volume":"64","author":"Mart\u00ednez-Banaclocha","year":"1999","journal-title":"Life Sci."},{"key":"10.1016\/j.ibneur.2026.08.014_bib28","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3389\/fneur.2014.00250","article-title":"Perturbed glucose metabolism: insights into multiple sclerosis pathogenesis","volume":"5","author":"Mathur","year":"2014","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ibneur.2026.08.014_bib29","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2174\/1570159X15666171109132650","article-title":"Pharmacological and non-pharmacological therapies of cognitive impairment in multiple sclerosis","volume":"16","author":"Miller","year":"2018","journal-title":"Curr. Neuropharmacol."},{"issue":"3","key":"10.1016\/j.ibneur.2026.08.014_bib30","doi-asserted-by":"crossref","first-page":"E196","DOI":"10.1097\/HTR.0000000000000976","article-title":"Changes in resting-state functional connectivity and cognitive-affective symptoms in patients with post-concussion syndrome treated with N-Acetyl Cysteine","volume":"40","author":"Monti","year":"2025","journal-title":"J. Head. Trauma. Rehab."},{"key":"10.1016\/j.ibneur.2026.08.014_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2026.108216","article-title":"N-Acetylcysteine is associated with changes in functional connectivity in patients with Parkinson's disease","volume":"144","author":"Monti","year":"2026","journal-title":"Park. Rel. Dis."},{"key":"10.1016\/j.ibneur.2026.08.014_bib32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fneur.2020.00088","article-title":"N-acetyl cysteine administration is associated with increased cerebral glucose metabolism in patients with multiple sclerosis: An exploratory study","volume":"11","author":"Monti","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ibneur.2026.08.014_bib33","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.2147\/PPA.S187529","article-title":"Clinical evaluation of dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis: efficacy, safety, patient experience and adherence","volume":"13","author":"Narapureddy","year":"2019","journal-title":"Patient Prefer. Adherence"},{"key":"10.1016\/j.ibneur.2026.08.014_bib34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fneur.2019.00153","article-title":"Functional Connectivity Changes After Initial Treatment With Fingolimod in Multiple Sclerosis","volume":"10","author":"Petsas","year":"2019","journal-title":"Front. Neurol."},{"issue":"13 Pt 2","key":"10.1016\/j.ibneur.2026.08.014_bib35","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1212\/01.wnl.0000306410.84794.4d","article-title":"Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment","volume":"70","author":"Polman","year":"2008","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ibneur.2026.08.014_bib36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00415-026-13665-9","article-title":"Disrupted and reorganized connectivity of brain networks in multiple sclerosis: a systematic review and meta-analysis of resting-state functional MRI","volume":"273","author":"Qu","year":"2026","journal-title":"J. Neurol."},{"key":"10.1016\/j.ibneur.2026.08.014_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2022.103076","article-title":"Task- and resting-state fMRI studies in multiple sclerosis: From regions to systems and time-varying analysis. Current status and future perspective","volume":"35","author":"Rocca","year":"2022","journal-title":"NeuroImage Clin."},{"issue":"4","key":"10.1016\/j.ibneur.2026.08.014_bib38","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/1352458517699875","article-title":"Functional network connectivity abnormalities in multiple sclerosis: Correlations with disability and cognitive impairment","volume":"24","author":"Rocca","year":"2018","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.ibneur.2026.08.014_bib39","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1212\/WNL.48.6.1566","article-title":"Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study","volume":"48","author":"Roelcke","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.ibneur.2026.08.014_bib40","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1098\/rstb.1985.0168","article-title":"Oxidative stress: damage to intact cells and organs","volume":"311","author":"Sies","year":"1985","journal-title":"Philos. Trans. R. Soc. Lond. B. Biol. Sci."},{"issue":"7","key":"10.1016\/j.ibneur.2026.08.014_bib41","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.clinph.2017.04.006","article-title":"Neurophysiology of synaptic functioning in multiple sclerosis","volume":"128","author":"Stampanoni Bassi","year":"2017","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.ibneur.2026.08.014_bib42","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3389\/fneur.2018.00828","article-title":"Functional connectivity in multiple sclerosis: recent findings and future directions","volume":"9","author":"Tahedl","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ibneur.2026.08.014_bib43","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.neuroscience.2017.07.055","article-title":"Neuroimaging Techniques to Assess Inflammation in Multiple Sclerosis","volume":"403","author":"Tommasin","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.ibneur.2026.08.014_bib44","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/BF01958877","article-title":"Effects of cysteine and N-acetyl cysteine on GSH content of brain of adult rats","volume":"39","author":"Vina","year":"1983","journal-title":"Experientia"},{"key":"10.1016\/j.ibneur.2026.08.014_bib45","series-title":"Mental Health Summary Scales: A Users' Manual","article-title":"SF-36 Physical and","author":"Ware","year":"1994"},{"key":"10.1016\/j.ibneur.2026.08.014_bib46","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/brain.2012.0073","article-title":"Conn: A functional connectivity toolbox for correlated and anticorrelated brain networks","volume":"2","author":"Whitfield-Gabrieli","year":"2012","journal-title":"Brain Connect."},{"key":"10.1016\/j.ibneur.2026.08.014_bib47","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.neubiorev.2015.08.018","article-title":"Implications of cortical balanced excitation and inhibition, functional heterogeneity, and sparseness of neuronal activity in fMRI","volume":"57","author":"Xu","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"4","key":"10.1016\/j.ibneur.2026.08.014_bib48","article-title":"Dimethyl fumarate for multiple sclerosis","volume":"2015","author":"Xu","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"4","key":"10.1016\/j.ibneur.2026.08.014_bib49","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00109-019-01761-5","article-title":"Insight into the mechanism of action of dimethyl fumarate in multiple sclerosis","volume":"97","author":"Yadav","year":"2019","journal-title":"J. Mol. Med."},{"issue":"2","key":"10.1016\/j.ibneur.2026.08.014_bib50","doi-asserted-by":"crossref","DOI":"10.1093\/cercor\/bhad535","article-title":"Regional GABA levels modulate abnormal resting-state network functional connectivity and cognitive impairment in multiple sclerosis","volume":"34","author":"Zhang","year":"2024","journal-title":"Cereb. Cortex"}],"container-title":["IBRO Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242126001405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242126001405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:42:37Z","timestamp":1793810557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667242126001405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":50,"alternative-id":["S2667242126001405"],"URL":"https:\/\/doi.org\/10.1016\/j.ibneur.2026.08.014","relation":{},"ISSN":["2667-2421"],"issn-type":[{"value":"2667-2421","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PET-MRI effects of N-acetylcysteine in patients with multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"IBRO Neuroscience Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ibneur.2026.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Brain Research Organization.","name":"copyright","label":"Copyright"}]}}